Polyplex Corporation Limited has informed the Exchange about Investor Presentation
POLYPLEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Polyplex Corporation filed its investor presentation for Q4 FY25 and FY25. For Q4 FY25, sales revenue rose 4% QoQ to INR 1,736 crores ($200 million) on 1% volume growth to 88,226 MT, while normalized EBITDA jumped 10% QoQ to INR 187 crores ($22 million) at an 11% margin. PAT, however, turned negative at -INR 9 crores due to an unrealized FX loss of INR 105 crores on foreign currency loans. For the full year FY25, revenue grew 1% YoY to INR 6,869 crores ($812 million) with volumes up 9% to 342,685 MT and normalized EBITDA up 49% YoY to INR 752 crores ($89 million). The company outlined $76.5 million in growth capex including a new BOPET film line in India ($58 million) targeted for H2 FY26-27, and guided Q1 FY26 normalized EBITDA at $26 million. Polyplex remains ranked #2 globally (ex-China) in Thin BOPET film capacity, with 7 plants across 5 countries and a stable India AA- credit rating.
FY25 saw a strong 49% jump in normalized EBITDA showing margin recovery, supported by better specialty mix and D-PAC sales growth, which should be viewed positively by shareholders. However, the negative Q4 PAT due to large FX losses on inter-company loans is a watch item. The capex pipeline and margin improvement guidance from US expansion and D-PAC sales suggest management is confident in continued earnings momentum.